| |
| |
|
| Insider
Information: |
Yachmetz Philip K |
| Relationship: |
Co-President and CBO |
| City: |
Wyckoff |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
98,241 |
|
|
Indirect Shares
|
200 |
|
|
| Direct
Value |
$31,554 |
|
|
|
Indirect Value
|
$820 |
|
|
| Total
Shares |
98,441 |
|
|
| Total
Value |
$32,374 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Progenics Pharmaceuticals Inc |
PGNX |
VP, General Counsel |
2004-05-03 |
7,696 |
2004-05-03 |
200 |
Premium* |
|
|
Savient Pharmaceuticals Inc |
SVNTQ |
Co-President and CBO |
2013-10-15 |
90,545 |
2004-06-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SVNTQ |
Savient Pharmaceuticals I... |
EVP, Chief Business Officer |
• – – |
2008-01-03 |
4 |
S |
$24.26 |
$121,286 |
D/D |
(5,000) |
143,087 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
EVP, Chief Business Officer |
• – – |
2008-03-05 |
4 |
D |
$23.49 |
$221,406 |
D/D |
(9,425) |
149,596 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
EVP, Chief Business Officer |
• – – |
2008-01-02 |
4 |
S |
$23.47 |
$117,331 |
D/D |
(5,000) |
143,087 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
EVP, Chief Business Officer |
• – – |
2008-01-04 |
4 |
S |
$23.27 |
$116,331 |
D/D |
(5,000) |
143,087 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
EVP, Chief Business Officer |
• – – |
2008-01-08 |
4 |
S |
$23.15 |
$115,760 |
D/D |
(5,000) |
143,087 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
EVP, Chief Business Officer |
• – – |
2008-01-07 |
4 |
S |
$23.02 |
$115,106 |
D/D |
(5,000) |
143,087 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
EVP, Chief Business Officer |
• – – |
2008-03-05 |
4 |
A |
$23.01 |
$477,458 |
D/D |
20,750 |
159,021 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, General Counsel |
• – – |
2010-09-16 |
4 |
A |
$20.27 |
$464,548 |
D/D |
22,918 |
193,352 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, General Counsel |
• – – |
2010-09-16 |
4 |
D |
$20.27 |
$164,552 |
D/D |
(8,118) |
185,234 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
EVP, Chief Business Officer |
• – – |
2008-02-15 |
4 |
AS |
$20.01 |
$47,233 |
D/D |
(2,361) |
140,726 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
EVP, Chief Business Officer |
• – – |
2008-02-20 |
4 |
AS |
$20.01 |
$49,113 |
D/D |
(2,455) |
138,271 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, General Counsel |
• – – |
2004-05-03 |
4 |
AS |
$19.15 |
$38,502 |
D/D |
(2,000) |
7,696 |
|
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
EVP, Chief Business Officer |
• – – |
2008-04-14 |
4 |
AS |
$19.00 |
$71,919 |
D/D |
(3,785) |
145,811 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, General Counsel |
• – – |
2009-09-15 |
4 |
S |
$16.25 |
$60,938 |
D/D |
(3,750) |
178,323 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, General Counsel |
• – – |
2009-09-14 |
4 |
S |
$15.75 |
$59,063 |
D/D |
(3,750) |
182,073 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
EVP, Chief Business Officer |
• – – |
2007-12-10 |
4 |
AS |
$15.22 |
$118,344 |
D/D |
(7,774) |
143,087 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
EVP, Chief Business Officer |
• – – |
2007-02-15 |
4 |
AS |
$14.44 |
$44,045 |
D/D |
(3,051) |
109,007 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, General Counsel |
• – – |
2010-02-16 |
4 |
AS |
$13.79 |
$79,706 |
D/D |
(5,778) |
167,127 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, General Counsel |
• – – |
2009-12-09 |
4 |
AS |
$13.31 |
$72,118 |
D/D |
(5,418) |
172,905 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
EVP, Chief Business Officer |
• – – |
2007-03-05 |
4 |
AS |
$12.53 |
$261,639 |
D/D |
(20,881) |
154,666 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
EVP, Chief Business Officer |
• – – |
2007-03-05 |
4 |
A |
$12.51 |
$572,333 |
D/D |
45,750 |
175,547 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, General Counsel |
• – – |
2004-05-03 |
4 |
OE |
$12.29 |
$24,580 |
D/D |
2,000 |
0 |
|
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
EVP, Chief Business Officer |
• – – |
2007-04-12 |
4 |
AS |
$12.06 |
$45,904 |
D/D |
(3,805) |
150,861 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, General Counsel |
• – – |
2011-02-14 |
4 |
AS |
$9.88 |
$31,724 |
D/D |
(3,210) |
182,024 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Gen Counsel and Secretary |
• – – |
2003-07-01 |
4 |
A |
$9.84 |
$14,937 |
D/D |
1,518 |
5,695 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
